Press Coverage

Merck vs. Pfizer’s COVID-19 Antiviral Pills: 11 Notes

Short article about the difference between the COVID-19 antiviral pills made by Merck and Pfizer mentions ISMP’s January 3, 2022, alert that patients with severe renal impairment should not receive the drug, while those with moderate renal impairment should receive a dose reduction.

For the full text, visit Becker’s Hospital Review online.

More News

I knew if I wanted to become a subject matter expert and advance through the ranks of medication safety specialists, I needed to align myself with the organization considered the gold standard for medication safety information.